94 related articles for article (PubMed ID: 27634022)
21. Knockdown of ANXA1 suppresses the biological behavior of human NSCLC cells in vitro.
Fang Y; Guan X; Cai T; Long J; Wang H; Xie X; Zhang Y
Mol Med Rep; 2016 May; 13(5):3858-66. PubMed ID: 27035116
[TBL] [Abstract][Full Text] [Related]
22. Circadian clock gene Per2 downregulation in non‑small cell lung cancer is associated with tumour progression and metastasis.
Xiang R; Cui Y; Wang Y; Xie T; Yang X; Wang Z; Li J; Li Q
Oncol Rep; 2018 Nov; 40(5):3040-3048. PubMed ID: 30226549
[TBL] [Abstract][Full Text] [Related]
23. miR-204 suppresses non-small-cell lung carcinoma (NSCLC) invasion and migration by targeting JAK2.
Wang P; Lv HY; Zhou DM; Zhang EN
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323056
[TBL] [Abstract][Full Text] [Related]
24. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer.
Kedmi M; Ben-Chetrit N; Körner C; Mancini M; Ben-Moshe NB; Lauriola M; Lavi S; Biagioni F; Carvalho S; Cohen-Dvashi H; Schmitt F; Wiemann S; Blandino G; Yarden Y
Sci Signal; 2015 Mar; 8(368):ra29. PubMed ID: 25783158
[TBL] [Abstract][Full Text] [Related]
25. [Expression and clinical significance of miR-23a and metastasis suppressor 1 in colon carcinoma].
Tang HL; Deng M; Liao QJ; Zeng X; Zhou XT; Su Q
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):28-32. PubMed ID: 22455847
[TBL] [Abstract][Full Text] [Related]
26. Inversin correlates with the malignant phenotype of non-small cell lung cancer and promotes the invasiveness of lung cancer cells.
Jiang GY; Zhang Y; Zhang XP; Lin XY; Yu JH; Wang EH
Tumour Biol; 2017 Jun; 39(6):1010428317691177. PubMed ID: 28618971
[TBL] [Abstract][Full Text] [Related]
27. Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC.
Lin HC; Zhang FL; Geng Q; Yu T; Cui YQ; Liu XH; Li J; Yan MX; Liu L; He XH; Li JJ; Yao M
J Proteome Res; 2013 Jul; 12(7):3423-33. PubMed ID: 23713811
[TBL] [Abstract][Full Text] [Related]
28. RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion.
Han Y; Dong Q; Hao J; Fu L; Han X; Zheng X; Wang E
Tumour Biol; 2016 Apr; 37(4):4865-71. PubMed ID: 26526576
[TBL] [Abstract][Full Text] [Related]
29. p63 controls cell migration and invasion by transcriptional regulation of MTSS1.
Giacobbe A; Compagnone M; Bongiorno-Borbone L; Antonov A; Markert EK; Zhou JH; Annicchiarico-Petruzzelli M; Melino G; Peschiaroli A
Oncogene; 2016 Mar; 35(12):1602-8. PubMed ID: 26119942
[TBL] [Abstract][Full Text] [Related]
30. Glypican-5 is a novel metastasis suppressor gene in non-small cell lung cancer.
Yang X; Zhang Z; Qiu M; Hu J; Fan X; Wang J; Xu L; Yin R
Cancer Lett; 2013 Dec; 341(2):265-73. PubMed ID: 23962560
[TBL] [Abstract][Full Text] [Related]
31. Del-1 overexpression potentiates lung cancer cell proliferation and invasion.
Lee SH; Kim DY; Jing F; Kim H; Yun CO; Han DJ; Choi EY
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):92-8. PubMed ID: 26545781
[TBL] [Abstract][Full Text] [Related]
32. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of CLPTM1L expression and its effects on migration and invasion of human lung cancer cells.
Ni Z; Chen Q; Lai Y; Wang Z; Sun L; Luo X; Wang X
Cancer Biomark; 2016; 16(3):445-52. PubMed ID: 27062701
[TBL] [Abstract][Full Text] [Related]
34. MTSS1 overexpression correlates with poor prognosis in colorectal cancer.
Wang D; Xu MR; Wang T; Li T; Zhu Jw
J Gastrointest Surg; 2011 Jul; 15(7):1205-12. PubMed ID: 21562916
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2.
Kong XM; Zhang GH; Huo YK; Zhao XH; Cao DW; Guo SF; Li AM; Zhang XR
Int J Clin Exp Pathol; 2015; 8(10):12845-52. PubMed ID: 26722475
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.
Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
Oncol Rep; 2013 Oct; 30(4):1639-44. PubMed ID: 23842884
[TBL] [Abstract][Full Text] [Related]
38. Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer.
Wang S; Pan H; Liu D; Mao N; Zuo C; Li L; Xie T; Huang D; Huang Y; Pan Q; Yang L; Wu J
Int J Oncol; 2015 Feb; 46(2):809-17. PubMed ID: 25434755
[TBL] [Abstract][Full Text] [Related]
39. MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma.
Fan H; Chen L; Zhang F; Quan Y; Su X; Qiu X; Zhao Z; Kong KL; Dong S; Song Y; Chan TH; Guan XY
Oncogene; 2012 May; 31(18):2298-308. PubMed ID: 21909138
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
